Citron's Left Can't Halt HK Case Over Evergrande Report
A Hong Kong tribunal has rejected a bid by Andrew Left of Citron Research, who recently made headlines with allegations against Valeant Pharmaceuticals, to stay civil claims against him by the city's Securities and...To view the full article, register now.
Already a subscriber? Click here to view full article